TOP HEADLINES

Featured Story

  • USDA speeds development of bird flu vaccine as fears of revived virus mount

    The H5N2 virus that has wiped out 48 million chickens and turkeys has waned of late, thanks to warm temperatures, but scientists are worried that the virus will return in the fall, as migrating wild birds fly south for the winter. So the USDA is working hard to test a vaccine, license it for mass production, and stockpile it around the country.

IDEXX shares climb on record diagnostics placements and Q2 earnings gain

Veterinary diagnostics maker IDEXX reported on Thursday that its revenues for the second quarter grew 6% year over year to $413 million, as placements of its blood analysis systems hit a record of 900 units for the period. Placements of its Catalyst One next-generation chemistry analyzer skyrocketed 44% to an all-time record of 1,100 units, the company said in a press release announcing the results.

Schein misses Q2 estimates on currency woes and sales challenges

Distributor Henry Schein, which is undergoing a major expansion of its animal health business, reported that earnings in the second quarter grew 8% year over year to $123.2 million or $1.46 per diluted share, on sales that rose a half-percent to $2.6 billion.

Heska doubles Q2 operating income but misses on revenue

Veterinary diagnostics maker Heska's stock has more than doubled since last year, but it's clearly experiencing some growing pains. On Wednesday, Heska missed analysts' sales targets for the second quarter, reporting year-over-year revenue growth of 4% to 23.9 million. Analysts had been expecting revenues of $24.3 million.

VCA ups 2015 guidance as Q2 sales and profits soar past expectations

Investors pushed shares of pet hospital chain VCA up more than 10% to $60 on Wednesday morning, after the Los Angeles company announced that its sales in the second quarter grew 12% year over year to a record of $548.8 million and its net income jumped 19% to $54.3 million, or $0.70 a share.

Report: 'Precision farming' set to revolutionize livestock care

The rise of the Internet, coupled with the increasing availability of big data, offers new tools to farmers that could make livestock production far more efficient in the future.

MORE NEWS

From Our Sister Sites

FiercePharma

Celgene is hedge fund manager Kyle Bass' latest patent target, it says--but the biotech isn't taking the news lying down.

FiercePharma

Sanofi's new CEO, Olivier Brandicourt, has a new company structure he is trotting out, a new potentially hot cholesterol-lowering drug to launch and now is able to take credit for a full quarter's worth of financial results that outperformed the street's best guesses. He even said today that Sanofi may be ready to do some wheeling and dealing, having so far stayed out of the M&A melee that has been going on all year.